Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-3-4
pubmed:abstractText
We found 10 individuals from 7 unrelated families among 170 severe combined immunodeficiency (SCID) patients who exhibited 9 different Janus kinase 3 (JAK3) mutations. These included 3 missense and 2 nonsense mutations, 1 insertion, and 3 deletions. With the exception of 1 individual with persistence of transplacentally transferred maternal lymphocytes, all infants presented with a T-B+NK- phenotype. The patient mutations all resulted in abnormal B-cell Janus kinase 3 (JAK3)-dependent interleukin-2 (IL-2)-induced signal transducer and activator of transcription-5 (STAT5) phosphorylation. Additional analyses of mutations permitting protein expression revealed the N-terminal JH7 (del58A) and JH6 (D169E) domain mutations each inhibited receptor binding and catalytic activity, whereas the G589S JH2 mutation abrogated kinase activity but did not affect c association. Nine of the 10 patients are currently alive from between 4 years and 18 years following stem cell transplantation, with all exhibiting normal T-cell function. Reconstitution of antibody function was noted in only 3 patients. Natural killer (NK) function was severely depressed at presentation in the 4 patients studied, whereas after transplantation the only individuals with normal NK lytic activity were patients 1 and 5. Hence, bone marrow transplantation is an effective means for reconstitution of T-cell immunity in this defect but is less successful for restoration of B-cell and NK cell functions.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2009-18
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:14615376-B-Lymphocytes, pubmed-meshheading:14615376-Cell Line, Transformed, pubmed-meshheading:14615376-Codon, Nonsense, pubmed-meshheading:14615376-DNA-Binding Proteins, pubmed-meshheading:14615376-Female, pubmed-meshheading:14615376-Gene Deletion, pubmed-meshheading:14615376-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:14615376-Humans, pubmed-meshheading:14615376-Infant, pubmed-meshheading:14615376-Interleukin-2, pubmed-meshheading:14615376-Janus Kinase 3, pubmed-meshheading:14615376-Killer Cells, Natural, pubmed-meshheading:14615376-Male, pubmed-meshheading:14615376-Milk Proteins, pubmed-meshheading:14615376-Mutation, Missense, pubmed-meshheading:14615376-Phenotype, pubmed-meshheading:14615376-Phosphorylation, pubmed-meshheading:14615376-Protein-Tyrosine Kinases, pubmed-meshheading:14615376-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14615376-STAT5 Transcription Factor, pubmed-meshheading:14615376-Severe Combined Immunodeficiency, pubmed-meshheading:14615376-Trans-Activators, pubmed-meshheading:14615376-United States
pubmed:year
2004
pubmed:articleTitle
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
pubmed:affiliation
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. rober060@mc.duke.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.